The new partnership of genomics and chemistry for accelerated drug development

Current Opinion in Chemical Biology

Volumn 1, Issue 2, 1997, Pages 151-156

  Veber, Daniel F ^a   Drake, Fred H ^a   Gowen, Maxine ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY; GENE LIBRARY; HUMAN; PHARMACEUTICS; REVIEW;

BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; GENOMIC LIBRARY; HUMANS;

EID: 0031197032     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(97)80003-8     Document Type: Article

References (37)

1. Toh H, Ono M, Saigo K, Miyata T: Retroviral protease-like sequence in the yeast transposon Ty 1. Nature 1985, 315:691.
2. Pearl L, Taylor W: A structural model for the retroviral proteases. Nature 1987, 329:351-354.
3. Vacca JP, Dorsey BD, Schleif WA, Levin RB, McDaniel SL, Darke PL, Zugay J, Quintero JC, Blahy OM, Roth E et al.: L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor. Proc Natl Acad Sci USA 1994, 91:4096-4100.
4. 2 symmetric inhibitor complexed to HIV-1 protease. Science 1990, 249:527-533.
5. Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IB, Galpin SA, Handa BK, Kay J, Krohn A et al.: Rational design of peptide-based HIV proteinase inhibitors. Science 1990, 248:358-361.
6. Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann RD, Bult CJ, Kerlavage AR, Sutton G, Kelley JM et al.: The minimal gene complement of mycoplasma genitalium. Science 1995, 270:397-403.
7. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb J-F, Dougherty BA, Merrick JM et al.: Whole-genome random sequencing and assembly of haemophilus influenzae Rd. Science 1995, 269:496-512. The entire genomic sequence of Haemophilus influenzae is presented.
8. Strauss EJ, Falkow S: Microbial pathogenesis: genomics and beyond. Science 1997, 276:707-712.
9. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, Galibert F, Hoheisel JD, Jacq C, Johnston M et al.: Life with 6000 genes. Science 1996, 274:546, 563-567.
10. Adams MD, Kerlavage AR, Fleischmann RD, Fuldner RA, Bult CJ, Lee NH, Kirkness ER, Weinstock KG, Gocayne JD, White O et al.: Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995, 377:3-174. The authors present an analysis of the EST database sequences.
11. Haseltine WA: Discovering genes for new medicines. Sci Am 1997, 92-97.
12. Drake FH, Dodds R, James I, Connor J, Debouck C, Richardson S, Lee-Rykaczewski E, Rieman D, Barthlow R, Hastings G, Gowen M: Cathepsin K but not cathepsin B, L or S is abundantly expressed in human osteoclasts. J Biol Chem 1996, 271:12511-12516. The authors analyzed the contents of a cDNA library generated from human osteoclast cells. Cathepsin K, a putative cysteine protease, was isolated and was subsequently shown [19] to be involved in bone resorption in vivo. Without a cDNA library, it is unlikely that this protein would have been isolated. Research efforts are focusing on developing inhibitors of this protease for treatment of osteoporosis.
13. Price LA, Kajkowski EM, Hadcock JR, Ozenberger BA, Pausch MH: Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway. Mol Cell Biol 1995, 15:6188-6195.
14. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW: Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996, 93:10614-10619.
15. Stracher T, Abitbol M, Davidson D, Beckmann JS: A new dimension for the human genome project: towards comprehensive expression maps. Nat Genet 1997, 16:126-132. The authors present an update on methods used to analyze the tissue specific expression of genes identified in the human genome project.
16. Suda T, Nakamura I, Jimi E, Takahashi N: Regulation of osteoclast function. J Bone Miner Res 1997, 12:869-879.
17. James IE, Walsh S, Dodds RA, Gowen M: The production and characterization of osteoclast-selective monoclonal antibodies which distinguish between multinucleated cells derived from different human tissues. J Histochem Cytochem 1991, 39:905-914.
18. Bossard MJ, Tomaszek TA, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, Drake FH, Gowen M, Levy MA: Proteolytic activity of cathepsin K: expression, purification, activation and substrate identification. J Biol Chem 1996, 271:12517-12524.
19. Votta B, Levy MA, Badger A, Dodds R, James I, Thompson SK, Bossard MJ, Carr T, Connor J, Tomaszek TA et al.: Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res 1997, in press.
20. •], the crystal structures of Cathepsin K complexed with a number of inhibitors are presented. Knowledge of these structures should aid in the design of new inhibitors.
21. •].
22. Rood J, Van Horn S, Drake FH, Gowen M, Debouck C: Genomic organization and chromosome localization of the human cathepsin K gene. Genomics 1997, 41:169-176.
23. Gelb BD, Shi GP, Heller M, Weremowicz S, Morton C, Desnick RJ, Chapman HA: Structure and chromosomal assignment of the human cathepsin-K gene. Genomics 1997, 41:258-262.
24. Gelb BD, Shi G-P, Chapman HA, Desnic RJ: Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996, 273:1236-1238.
25. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y: A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J Biol Chem 1996, 271:11325-11329. The authors report the isolation of the cDNA for CGRP (calcitonin gene-related peptide), a G-protein-coupled receptor.
26. Stellato C, Collins O, Ponath PD, Soler D, Newman W, Lasrosa G, Li H, White J, Schwiebert LM, Bickel C et al.: Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 1997, 99:926-936.
27. Szostak JW, Osborne SE, Ellington AD, Breaker R, Smith GP, Petrenko VA, Lam KS, Lebl M, Houghten RA, Pirrung MC et al.: Combinatorial chemistry. Chem Rev 1997, 97:347-510.
28. Smith GP, Petrenko VA: Phage display. Chem Rev 1997, 97:391-410.
29. Wrighton NC, Farrell FX, Chang R, Kashyap AK, Barbone FP, Mulcahy LS, Johnson DL, Barrett RW, Jolliffe LK, Dower WJ: Small peptides as potent mimetics of the protein hormone erythropoietin. Science 1996, 273:458-463. The authors report the isolation of a small (20-residue peptide) agonist at the erythropoietin (EPO) receptor by screening a combinatorial phage display library. Natural ligands of EPO are large folded proteins, and searches for smaller ligands have been unfruitful until now.
30. •] effectively dimerizes to form a large ligand.
31. Wilson WA, Clark MT, Pellmar TC: Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 1977, 196:441-444.
32. Patchett AA, Harris E, Tristram EW, Wyvratt MJ, Wu MT, Taub D, Peterson ER, Ikeler TJ, Broeke J, Payne LG et al.: A new class of angiotensin-converting enzyme inhibitors. Nature 1980, 288:280-283.
33. Brady SF, Lewis SD, Colton CD, Staufer KJ, Sisko JT, Ng AS, Homnic CF, Bogusky MJ, Shafer JA, Veber DF, Nutt RF: Amide and α-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization. Bioorg Med Chem 1995, 3:1063-1078.
34. i of 0.09 nM, but lacks useful oral bioavailability.
35. •] by replacement of the normally critical but chemically troublesome ketoamide by a hydrogen.
36. Brady SF, Staufer KJ, Smith GM, Lewis SD, Lucas R, Naylor-Olsen AM, Ramjit H, Lumma WC: Development of novel potent small molecule inhibitors of thrombin: co-application of structure-based design and rapid multiple analog synthesis on solid support toward lead optimization [abstract]. The Second Winter Conference on Medicinal Chemistry and Bioorganic Chemistry. 1997 January 26-31, Steamboat Springs, Colorado.
37. Tucker TJ, Lumma WC, Mulichak AM, Chen Z, Naylor-Olsen AM, Lewis SD, Lucas R, Freidinger RM, Kuo LC: Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site. J Med Chem 1997, 40:830-832.